Ashley Ross

I'll research this attorney before drafting. Let me run several searches.

Let me verify the firm bio page and education/bar details.

Specialty / focus areas. Ashley L. B. Ross is a Kirkland & Ellis IP partner whose practice centers on patent and trade-secrets litigation, with a substantial life-sciences and Hatch-Waxman ANDA docket. Kirkland's Chambers USA "Life Sciences and Pharma IP Litigation" contribution (2025), which she co-authored, describes her cases as spanning small molecules, pharmaceutical compositions, therapeutic antibodies, DNA amplification technology, biofuels, and mechanical and medical devices; it notes that she holds a degree in molecular and cellular biology, argues Markman hearings, and works patent-dance/discovery practice through trial. Her tracked matter — Abbott Diabetes Care Inc. v. Dexcom, Inc., one prong of the consolidated Abbott/Dexcom continuous-glucose-monitor patent litigation in the District of Delaware — is a medical-device/consumer-health dispute rather than a pharma ANDA case, and is consistent with that device-side experience.

Side preference. On the authoritative case list she is 1-for-1 on the plaintiff side, as lead counsel. Public sources are consistent with a patent-holder/brand-company orientation rather than an NPE/PAE practice: her reported engagements include Abbott, Astellas, Bristol Myers Squibb, Boehringer Ingelheim, Impax/AstraZeneca, Microspherix, Finch Therapeutics/University of Minnesota, and Merus as plaintiffs or patent owners, alongside defense-side representations for Teva, Actavis and various ANDA defendants. So: primarily brand/patent-owner side, with meaningful defendant-side work in the same life-sciences space — not an NPE prosecution practice.

Firm context and notable matters. All publicly identified appearances are at Kirkland & Ellis (New York office, 601 Lexington Avenue); no prior firm is disclosed in the sources reviewed, and her litigation career appears to have been built at Kirkland, where she is now a partner. Verified results include: Astellas Pharma v. Ascent Pharmaceuticals — after an October 2025 Delaware bench trial, a directed verdict of infringement on four asserted Myrbetriq® patents, with the claims later held not invalid and not unenforceable, a team win that The American Lawyer's Litigation Daily named a "Litigator of the Week" runner-up (Kirkland's March 2026 announcement lists her on the team); Ferring Pharmaceuticals/Rebiotix v. Finch Therapeutics (D. Del.) — August 2024 jury finding of willful infringement of three microbiome patents and a $25 million verdict plus royalties; Galderma v. Teva — Delaware bench ruling that all asserted rosacea-formulation patents were invalid, later settled on appeal; Impax v. Lannett — judgment of validity and infringement on a migraine nasal spray, affirmed on Federal Circuit appeal; and Merus v. Regeneron (S.D.N.Y.) — defense counterclaim finding a Regeneron patent unenforceable. She also worked Butamax v. Gevo (biofuels, resolved by cross-license) and an ITC hearing for Baxter against Ethicon.

PTAB / IPR and credentials. The sourced record shows IPR experience rather than a high-volume PTAB specialty: she reportedly defended Microspherix's implantable-contraceptive patent in inter partes review and drafted a successful IPR petition invalidating a challenger patent for an oil-and-gas technology client, and her Chambers bio advertises trade-secrets and patent litigation rather than a standing PTAB docket — I found no evidence of a regular IPR/PGR practice, so that should be treated as occasional. On bar admission and education, the sources I could verify are thin: the Chambers entry confirms a molecular/cellular biology degree, and Best Lawyers lists her as New York–recognized (since 2026) in Intellectual Property Law and Litigation–Patent, with Law360 and court filings placing her in Kirkland's New York office — but I could not independently verify her law school or bar admissions, so those should be confirmed directly rather than stated here. Note also the name is shared by other attorneys; the profile above is limited to the Kirkland IP partner Ashley L. B. Ross (a.k.a. Ashley Lauren Borom Ross).